FLAG Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
FLAG Therapeutics General Information
Description
Developer of small-molecule therapeutics designed for difficult-to-treat cancers. The company's technology utilizes proprietary drug discovery platforms to create water-soluble, multi-acting compounds that cross the blood-brain barrier and evade drug resistance mechanisms, enabling patients with investigational treatments for unmet medical needs in oncology, including pediatric gliomas, ovarian cancer, and pancreatic cancer.
Contact Information
Website
www.flagtherapeutics.comCorporate Office
- 9168 Wooden Road
- Raleigh, NC 27617
- United States
Corporate Office
- 9168 Wooden Road
- Raleigh, NC 27617
- United States
FLAG Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 01-Jul-2019 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 09-Jan-2019 | Completed | Startup | |||
| 3. Debt - General | 21-Nov-2018 | Completed | Startup | |||
| 2. Grant | 01-Jan-2017 | $1.5M | $250K | Completed | Startup | |
| 1. Debt - General | 06-Mar-2015 | $250K | $250K | Completed | Startup |
FLAG Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FLAG Therapeutics Comparisons
Industry
Financing
Details
FLAG Therapeutics Competitors (2)
One of FLAG Therapeutics’s 2 competitors is Sutro Biopharma, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | ||||
| Chimerix | Corporate Backed or Acquired | Durham, NC |
FLAG Therapeutics Signals
FLAG Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Springhood | Venture Capital | Minority |
FLAG Therapeutics FAQs
-
When was FLAG Therapeutics founded?
FLAG Therapeutics was founded in 2013.
-
Where is FLAG Therapeutics headquartered?
FLAG Therapeutics is headquartered in Raleigh, NC.
-
What is the size of FLAG Therapeutics?
FLAG Therapeutics has 3 total employees.
-
What industry is FLAG Therapeutics in?
FLAG Therapeutics’s primary industry is Drug Discovery.
-
Is FLAG Therapeutics a private or public company?
FLAG Therapeutics is a Private company.
-
What is FLAG Therapeutics’s current revenue?
The current revenue for FLAG Therapeutics is .
-
How much funding has FLAG Therapeutics raised over time?
FLAG Therapeutics has raised $4.05M.
-
Who are FLAG Therapeutics’s investors?
Springhood has invested in FLAG Therapeutics.
-
Who are FLAG Therapeutics’s competitors?
Sutro Biopharma and Chimerix are competitors of FLAG Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process